Catálogo de publicaciones - revistas
Science
Resumen/Descripción – provisto por la editorial
No disponible.
Palabras clave – provistas por la editorial
No disponibles.
Disponibilidad
| Institución detectada | Período | Navegá | Descargá | Solicitá |
|---|---|---|---|---|
| No detectada | desde mar. 1997 / hasta dic. 2023 | Science Journals |
Información
Tipo de recurso:
revistas
ISSN impreso
0036-8075
ISSN electrónico
1095-9203
Editor responsable
American Association for the Advancement of Science (AAAS)
País de edición
Estados Unidos
Fecha de publicación
1880-
Cobertura temática
Tabla de contenidos
Ras, STAT3, and Transformation
Palabras clave: Multidisciplinary.
Pp. 1615-1615
NMR Under Stormy Conditions
Palabras clave: Multidisciplinary.
Pp. 1615-1615
Integrating Organ Induction
Palabras clave: Multidisciplinary.
Pp. 1615-1615
Of Life, Limb, and a Small RNA
Palabras clave: Multidisciplinary.
Pp. 1615-1615
BDNF and Drug Dependence
Palabras clave: Multidisciplinary.
Pp. 1615-1615
Synthetic Centromere
Palabras clave: Multidisciplinary.
Pp. 1615-1615
Out With the Old, In With the New?
Roger Pedersen
<jats:p>President Obama's recent announcement of a new policy for Federal Funding of stem cell research changes the landscape for this important area of biomedicine in the United States. His Executive Order and the subsequent draft guidelines of the National Institutes of Health (NIH) remove a major existing limitation on federal support for research using pluripotent human embryonic stem cells (hESCs). These stem cells can specialize into all body cell types. Thus, in principle they can be used to produce a wide range of tissues for therapeutic use. In addition, their study will very likely generate new insights into human early developmental mechanisms. The new Obama policy promises to speed research by making many new hESC lines eligible for federally funded studies. But the draft NIH guidelines accompanying the new policy need revision, because their donor consent rules for embryos used to generate hESCs would make some—and perhaps even all—of the previously approved hESCs ineligible for further federal funding. This would needlessly hinder progress in the stem cell field, and reasonable exceptions should be made to correct this unintended outcome.</jats:p>
Palabras clave: Multidisciplinary.
Pp. 1617-1617